Observational studyAddiction (Abingdon, England)2024

Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients.

Rachael K Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.